- Incoming EU Health Chief Pledges Action on Patient Drug Info (PharmaTimes)
- FDA Warning on Fake Versions of GSK’s Weight Loss Drug (PharmaTimes)
- J&J Recalls More Products for Contamination (Securing Pharma)
- FDA Extends Review Period for Tarceva Application for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer (PharmaLive)
- Pfizer, Teva Head Race for Ratiopharm – Report (PharmaTimes)
- AstraZeneca Embraces Personalised Medicine with Dako Deal (PharmaTimes)
- Forest Laboratories, Inc. Reports Fiscal Third Quarter 2010 Earnings Per Share of $0.69, Including One-Time Charges Totaling $0 (TradingMarkets.com)
- FDA to Toughen Warnings against Sun Beds (The Washington Post)
- GenVec Inks Licensing Deal with Novartis Z (Reuters)
- Novartis Providing Equivalent of Over USD 2.5 million for Victims of Haiti Earthquake (World Pharma News)
- In Recall, a Role Model Stumbles (The New York Times)
SUBSCRIBE